EU advances plans to reduce reliance on drug imports - Pharmaceutical Technology

Agreement on the proposed Critical Medicines Act (CMA) represents an important step for boosting the EU pharma sector. Agreement on the proposed Critical Medicines Act (CMA) represents an important step for boosting the EU pharma sector. Medicines such as antibiotics, vaccines, and products for chronic and rare diseases stand to benefit from the new framework. Credit: Photo Nature Travel/Shutterstock.com. The European Union (EU) has taken a major step towards ushering in new rules that will safeguard the supply of critical medicines and help avoid shortages, reflecting the latest step by the region to bolster its pharma ecosystem amid international pressures.…

Source: Pharmaceutical Technology